Stock IVBIY INNOVENT BIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Innovent Biologics, Inc. OTC Markets

Equities

IVBIY

US45783L1017

Market Closed - OTC Markets
Other stock markets
 15:01:58 01/04/2024 BST 		5-day change 1st Jan Change
19.48 USD +4.39% Intraday chart for Innovent Biologics, Inc. -.--% -6.75%
05-28 Innovent Biologics, Inc. Announces Picankibart Achieved Primary Endpoints in A Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to the NDA to the NMPA CI
05-21 Chinese Regulator Accepts Innovent Biologics' New Drug Application for Thyroid Eye Disease Drug MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CSL LIMITED Stock CSL Limited
 89.87B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 37.57B
UCB Stock UCB
 26.47B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 14.25B
INCYTE CORPORATION Stock Incyte Corporation
 12.99B
  1. Stock Market
  2. Equities
  3. 1801 Stock
  4. IVBIY Stock
  5. Charts Innovent Biologics, Inc.
  6. Sector Chart